Current trials

 

MOSAIC (Myopia outcome study of atropine in children)

Prof. Loughman and Prof. Flitcroft are leading MOSAIC trial, the first European clinical trial to control the development of myopia, funded by HRB/MRCG and Fighting Blindness. Read more...

 

ENIGMA (European nutrition in glaucoma management trial)

We are currently recruiting patients with glaucoma to participate in ENIGMA, a study evaluating a dietary supplement as an adjunct therapy for glaucoma.

Read more...

         Twitter

 

Is your child at risk of blindness? We are recruiting shortsighted children in Ireland to participate in MOSAIC, the first European drug trial designed to control myopia development! Please direct message or email us at mosaic@dit.ie if interested! #Mosaictrial #myopia

— ABOUT CERI—

What we do

The Centre for Eye Research Ireland (CERI) is an ophthalmic research centre with cutting edge facilities specialising in:

 

  • Eye Health, Digital Health and Vision Enhancement
  • Technology Development &Transfer, Commercial Innovation and Intellectual Property creation
  • Fully customisable and integrated Clinical Trial solutions and implementation

 

The CERI team has designed and delivered more than 10 Clinical Trials, including COMPASS, the Polysoft Comfort Trial and the Macular Pigment in Glaucoma Trial. We have also provided consultancy services to  a number of collaborative studies (TILDA, CARDS, CREST). Two clinical trials are currently underway funded by the HRB/MRCG, Fighting Blindness and Alliance Pharma, focused on novel interventions for glaucoma and myopia.

 

Our Facility

DIT Grangegorman

CERI is based at the Environmental Sustainability and Health Institute (ESHI).

 

ESHI is a dedicated national translational research platform, uniquely based on collaboration between TU Dublin, the Health Service Executive (HSE) and Dublin City Council (DCC), thereby positioning CERI to achieve maximal impact on health policy and practice.

 

Our infrastructure comprises two cutting edge Vision and Eye Health labs allowing us to engage in a wide array of basic, applied and clinical research. The broader facilities within ESHI allow CERI to expand its range of research to Nutrition, Health Informatics, Human Biomonitoring, Bioengineering and Technology translation.

 

ENIGMA trial

European Nutrition in Glaucoma Management Trial

 

 

 

 

 

 

 

Glaucoma, which is a progressive optic neuropathy, is the second leading cause of global blindness. Current therapeutic options are limited, and typically fail to arrest disease progression for the majority of glaucoma patients. ENIGMA trial is designed to determine the impact of dietary supplementation on vision and quality of life including symptoms of glare among glaucoma subjects.

CHAMP trial

Children using atropine for reduction of myopia progression

 

 

 

 

 

 

 

The primary objective of CHAMP is to evaluate the safety & efficacy of 2 concentrations of atropine sulfate ophthalmic solution (0.01% & 0.02%) compared to placebo (vehicle) for the reduction of progression of myopia over a 3-year treatment period.

Priority Research Areas

— OUR PRIORITIES —

— PROJECTS —

MOSAIC trial

Myopia Outcome Study of Atropine in Children

 

 

 

 

 

There is no current therapeutic approach to the control and prevention of myopia, which is expected to affect one in three people worldwide by 2020, and represents the only major cause of blindness that is untreatable.

 

CHAMP and MOSAIC are the first European trials to explore the efficacy and safety of atropine for myopia prevention in a Caucasian population.

—THE TEAM—

CERI Team

Prof. James Loughman

Professor of Optometry

and Vision Science

Head of CERI

Prof. Ian Flitcroft

Consultant Ophthalmologist,

Mater Hospital

Adjunct Professor of Vision Science

Principal Investigator at CERI

Dr. John Butler

Lecturer, School of

Mathematical Sciences

Principal Investigator at CERI

Saoirse McCrann

PhD Researcher

Clinical optometrist

Niamh Burke

PhD Researcher

Clinical optometrist

Michael Moore

PhD Researcher

Academic optometrist

Grainne Scanlon

PhD Researcher

Academic optometrist

Dr Catriona Barrett, PhD

Academic optometrist

Dr. Nabin Paudel, PhD

Postdoctoral researcher

Ekaterina Loskutova, MD

Clinical trial coordinator

PhD Researcher

Dr Kajal Shah, PhD

Adjunct research fellow

—CONTACT—

Centre for Eye Research Ireland

GW 205-207

The Greenway Hub

TU Dublin Grangegorman

Dublin 7

+353  1 402 5413/ 5412

 
 
 

Navigate

Address

Centre for Eye Research Ireland

GW 205-207

The Greenway Hub

TU Dublin Grangegorman

Dublin 7

+353 1 402 5413/ 5412

Home

About

Our priorities

Projects

Team

Contact

Contact us

ceri@dit.ie

Linkedin

Facebook

Twitter

Our collaborators

DIT Grangegorman
DIT Grangegorman

Navigate

Address

Centre for Eye Research Ireland

GW 205-207

The Greenway Hub

TU Dublin Grangegorman

Dublin 7

+353 1 402 5413/ 5412

Home

About

Our priorities

Projects

Team

Contact

Contact us

ceri@dit.ie

Linkedin

Facebook

Twitter

Our collaborators

 
DIT Grangegorman

Navigate

Address

Centre for Eye Research Ireland

GW 205-207

The Greenway Hub

TU Dublin Grangegorman

Dublin 7

+353 1 402 5413/ 5412

Home

About

Our priorities

Projects

Team

Contact

Contact us

ceri@dit.ie

Linkedin

Facebook

Twitter

Our collaborators

DIT Grangegorman
DIT Grangegorman

Navigate

Address

Centre for Eye Research Ireland

GW 205-207

The Greenway Hub

TU Dublin Grangegorman

Dublin 7

+353 1 402 5413/ 5412

Home

About

Our priorities

Projects

Team

Contact

Contact us

ceri@dit.ie

Linkedin

Facebook

Twitter

Our collaborators

DIT Grangegorman

Navigate

Address

Contact us

Centre for Eye Research Ireland

GW 205-207

The Greenway Hub

TU Dublin Grangegorman

Dublin 7

+353 1 402 5413/ 5412

Home

About

Our priorities

Projects

Team

Contact

ceri@dit.ie

Linkedin

Facebook

Twitter

Our collaborators

DIT Grangegorman

Myopia

1 billion people at risk of blindness by 2050 due to myopia. We is working to develop myopia control technologies and evaluate candidate pharmaceutical therapies.

   >  Read more

Nutrition for Eye Health

Targeted nutrition can benefit eye health and visual performance. We are conducting research to evaluate the role of nutrition and nutraceuticals for prevention of eye disease and enhancement of vision for individuals with vision problems or those with critical visual demands, such as elite sports athletes.

   >  Read more

Technology Development

We are currently developing a novel Myopia control technology in collaboration with DIT Nanolab, and have numerous pipeline projects for blindness prevention.

   >  Read more

Glaucoma

Glaucoma is a progressive disease that can cause blindness and a significant impact on quality of life If not carefully controlled. We are currently evaluating a novel nutritional therapy for glaucoma.

   >  Read more

Dry eye

Targeted nutritional supplementation can effectively fight against ocular surface inflammation, which is the key mechanism of ocular surface injury, as both the cause and consequence of cell damage.

   >  Read more

Navigate

Address

Contact us

Centre for Eye Research Ireland

GW 205-207

The Greenway Hub

TU Dublin Grangegorman

Dublin 7

+353 1 402 5413/ 5412

Home

About

Our priorities

Projects

Team

Contact

ceri@dit.ie

Linkedin

Facebook

Twitter

Our collaborators

DIT Grangegorman
 
 
DIT Grangegorman

Address

Centre for Eye Research Ireland

GW 205-207

The Greenway Hub

TU Dublin Grangegorman

Dublin 7

+353 1 402 5413/ 5412

ceri@dit.ie

Our collaborators

DIT Grangegorman
DIT Grangegorman